Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Rheumatology 1, 67–68 (1 December 2005) | doi:10.1038/ncprheum0025
Recombinant osteoprotegerin suppresses bone resorption in juvenile Paget's disease
Abstract
Cundy T et al. (2005) Recombinant osteoprotegerin for juvenile Paget's disease. N Engl J Med 353: 918–923 Juvenile Paget's disease results from a mutation in the gene encoding osteoprotegerin, a protein that inhibits bone-resorbing osteoclast cells.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
